Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies CSO Laszlo Radvanyi Co-Authors Study in Journal of Immunotherapy

LOS ANGELES, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
September 05, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies to Present at the Rodman & Renshaw 16th Annual Global Investment Conference

LOS ANGELES, Sept. 5, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based...
August 20, 2014 16:05 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Names Elma Hawkins President and Chief Operating Officer

LOS ANGELES, Aug. 20, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
August 11, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies' Chief Scientific Officer to Present at Immunotherapies and Vaccines Summit

LOS ANGELES, Aug. 11, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
July 30, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Enters Clinical Trial Grant Agreement With Moffitt Cancer Center

LOS ANGELES, July 30, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
July 25, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Exclusive License Agreement With Moffitt Cancer Center

LOS ANGELES, July 25, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
July 23, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Leases New Research Laboratory

LOS ANGELES, July 23, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
June 23, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Appoints Dr. Laszlo Radvanyi as Chief Scientific Officer

LOS ANGELES, June 23, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
May 27, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies to Present at the Jefferies 2014 Global Healthcare Conference

LOS ANGELES, May 27, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based on...
April 07, 2014 12:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies' Lead Program With National Cancer Institute Demonstrates Positive Results in Patients With Stage 4 Metastatic Melanoma

LOS ANGELES, April 7, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...